Actinium Pharmaceuticals, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
AMEX
Actinium Pharmaceuticals, Inc. announces its 2025 Annual Meeting of Stockholders to address director elections, auditor ratification, and executive compensation advisory votes.
AMEX
Actinium Pharmaceuticals announces its 2024 Annual Meeting of Stockholders to be held on November 27, 2024, with proposals to elect directors and ratify the appointment of Marcum LLP as the independent auditor.